Medtronic anticipates the separation of its diabetes business unit into a wholly separate entity to complete within 18 months ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced its intent to separate its Diabetes ...

Medtronic has announced it intends to separate its diabetes business, which represented 8% of revenue and 4% of segment operating profit in fiscal year 2025, into a new standalone ...

Healthcare is undergoing a foundational shift, moving from a reactive, siloed approach to a proactive, networked and smart ...

Ireland: Medtronic plc has announced its intent to separate its Diabetes business into a new standalone company.The separation is expected to be completed within 18 months through a series ...

The poor don’t read GDP reports, but they feel every shock, every price hike, every day a little heavier than the last. The ...

More adults are opting for a type of vacation known as a sleepcation, where they try to get the rest they’ve been missing.

Thousands of severely obese children are being supported to lose weight and live healthier lifestyles thanks to the roll-out of specialist NHS clinics and new digital ‘smart scale’ technology to ...

Today, Akondi’s groundbreaking work not only honors her grandfather but holds the promise of transforming diabetic care for millions around the world. Akondi has been named a recipient of the Stanford ...

Here's how SHG Technologies combines AI and empathy to develop Smart Vision Glasses, transforming lives of India's visually impaired.

The following seven stocks are all "strong buys" at five or more Wall Street firms, and have zero sell ratings at present.

Medtronic (NYSE:MDT) announced today that it intends to separate its Diabetes business into a new standalone company.